Početna › Planoćelijski karcinom › Tennessee
Kliničke studije za Planoćelijski karcinom u državi Tennessee
7 studija za Planoćelijski karcinom traži sudionike na lokacijama u državi Tennessee.
Gradovi u državi Tennessee
Službeni tekst studije (engleski)
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06047379A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06561685Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. kol 2026. · NCT06819228Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT07460765Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 11. svi 2026. · NCT07217028High-Resolution PET-CT Imaging for Surgical Margin Visualization
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 8. svi 2026. · NCT06915454Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 15. kol 2025. · NCT04429542Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.